相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PD-L1 Expression and Comprehensive Molecular Profiling Predict Survival in Nonsmall Cell Lung Cancer: A Real-World Study of a Large Chinese Cohort
Yan Jin et al.
CLINICAL LUNG CANCER (2022)
Clinicopathological and molecular characteristics associated with PD-L1 expression in non-small cell lung cancer: a large-scale, multi-center, real-world study in China
Qiang Zheng et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
QuPath: The global impact of an open source digital pathology system
M. P. Humphries et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Automated PD-L1 Scoring for Non-Small Cell Lung Carcinoma Using Open-Source Software
Julia R. Naso et al.
PATHOLOGY & ONCOLOGY RESEARCH (2021)
ASCO 2020 non-small lung cancer (NSCLC) personal highlights
Lena Horvath et al.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY (2021)
Comparison of continuous measures across diagnostic PD-L1 assays in non-small cell lung cancer using automated image analysis
Moritz Widmaier et al.
MODERN PATHOLOGY (2020)
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
Nasser H. Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Improving the Diagnostic Accuracy of the PD-L1 Test with Image Analysis and Multiplex Hybridization
Matthew P. Humphries et al.
CANCERS (2020)
PD-L1 expression on routine samples of non-small cell lung cancer: results and critical issues from a 1-year experience of a centralised laboratory
Elena Vigliar et al.
JOURNAL OF CLINICAL PATHOLOGY (2019)
Programmed death ligand 1 immunohistochemistry in non-small cell lung carcinoma
Sylvie Lantuejoul et al.
JOURNAL OF THORACIC DISEASE (2019)
The Reproducibility of the Immunohistochemical PD-L1 Testing in Non-Small-Cell Lung Cancer: A Multicentric Italian Experience
Elena Vigliar et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Recent Progress in Rare Oncogenic Drivers and Targeted Therapy For Non-Small Cell Lung Cancer
Yijia Guo et al.
ONCOTARGETS AND THERAPY (2019)
The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors
Andrew A. Davis et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
A Multi-Institutional Study to Evaluate Automated Whole Slide Scoring of Immunohistochemistry for Assessment of Programmed Death-Ligand 1 (PD-L1) Expression in Non-Small Cell Lung Cancer
Clive R. Taylor et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2019)
PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs An Interclone Evaluation by Differently Trained Pathologists
Enrico Munari et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases
E. E. Vokes et al.
ANNALS OF ONCOLOGY (2018)
Deep Semi Supervised Generative Learning for Automated Tumor Proportion Scoring on NSCLC Tissue Needle Biopsies
Ansh Kapil et al.
SCIENTIFIC REPORTS (2018)
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer et al.
LANCET (2017)
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
Julie R. Brahmer et al.
LANCET ONCOLOGY (2017)
PD-L1 immunohistochemistry in clinical diagnostics of lung cancer: inter-pathologist variability is higher than assay variability
Hans Brunnstrom et al.
MODERN PATHOLOGY (2017)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
分享论文
